Pearl R G, Seiden L S
J Pharmacol Exp Ther. 1976 Sep;198(3):635-47.
Administration of d-amphetamine (2.5 mg/kg) or methylphenidate (20 mg/kg) decreased milk consumption in rats. When these drugs were administered daily, tolerance developed to this effect over the course of 20 days. Cross-tolerance to the effects on milk consumption occurred between d-amphetamine and methylphenidate over a 4-fold range of dose of both drugs. Administration of d-amphetamine (1.5 mg/kg) or methylphenidate (10 mg/kg) disrupted responding under differential-reinforcement-or-low-rate (DRL) contingencies. Both drugs increased response rate, decreased frequency of reinforcement and shifted the mode of the inter-response time distribution to the left. When the drugs were administered daily, tolerance developed to all these effects over the course of 20 days. Cross-tolerance to the effects on DRL behavior occurred between d-amphetamine and methylphenidate over a 4-fold range of dose of both drugs. Daily administration of d-amphetamine (2.5 mg/kg) but not of methylphenidate (20 mg/kg) resulted in decreased norepinephrine (NE) levels in brain; the decreased norepinephrine levels, which occur with repeated d-amphetamine administration, are believed to result from the storage in noradrenergic neurons of p-hydroxynorephedrine, a metabolite of d-amphetamine. Radioactivity was not detectable in brain 24 hours after the last of 15 daily doses of radiolabeled methylphenidate. These results suggest that d-amphetamine, but not methylphenidate, is metabolized to a compound which is stored in noradrenergic neurons. The existence of behavioral cross-tolerance between d-amphetamine and methylphenidate is therefore inconsistent with the hypothesis that tolerance to the behavioral effects of d-amphetamine is due to the metabolism of d-amphetamine to p-hydroxynorephedrine, a false transmitter in noradrenergic neurons.
给予大鼠右旋苯丙胺(2.5毫克/千克)或哌甲酯(20毫克/千克)会降低其牛奶摄入量。当每日给予这些药物时,在20天的过程中会产生对此效应的耐受性。在两种药物4倍剂量范围内,右旋苯丙胺和哌甲酯之间出现了对牛奶摄入量影响的交叉耐受性。给予大鼠右旋苯丙胺(1.5毫克/千克)或哌甲酯(10毫克/千克)会破坏差别强化低速率(DRL)条件下的反应。两种药物均增加反应率、降低强化频率,并使反应间隔时间分布模式向左移动。当每日给予这些药物时,在20天的过程中会产生对所有这些效应的耐受性。在两种药物4倍剂量范围内,右旋苯丙胺和哌甲酯之间出现了对DRL行为影响的交叉耐受性。每日给予右旋苯丙胺(2.5毫克/千克)而非哌甲酯(20毫克/千克)会导致脑内去甲肾上腺素(NE)水平降低;反复给予右旋苯丙胺后出现的去甲肾上腺素水平降低,被认为是由于右旋苯丙胺的代谢产物对羟基去甲麻黄碱储存在去甲肾上腺素能神经元中所致。在15次每日给予放射性标记的哌甲酯的最后一剂后24小时,脑内未检测到放射性。这些结果表明,右旋苯丙胺而非哌甲酯会代谢为一种储存在去甲肾上腺素能神经元中的化合物。因此,右旋苯丙胺和哌甲酯之间行为交叉耐受性的存在与以下假设不一致,即对右旋苯丙胺行为效应的耐受性是由于右旋苯丙胺代谢为去甲肾上腺素能神经元中的假递质对羟基去甲麻黄碱所致。